334
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Update of Recently (2016–2020) Designed Azepine Analogs and Related Heterocyclic Compounds with Potent Pharmacological Activities

Pages 2250-2268 | Received 09 Apr 2021, Accepted 06 Feb 2022, Published online: 24 Feb 2022
 

Abstract

Life-style changes, environmental pollution, and genetic factors have resulted in a large number of diseases to human beings. Though plant extracts have been widely used to counteract these diseases wherein the combined effect of the constituents was found to be responsible for the cure of a disease, activity of individual constituent was unknown. Further, naturally obtained heterocyclic compounds have been found to possess excellent pharmacological activity. In view of improvement of pharmacological activity, synthesis of derivatized heterocyclic compounds is considered as prime importance in drug-design. It is evident that azepine derivatives have been reported to possess a wide range of pharmacological activity. Recently, the critical reviews on pharmacology of azepines have not been reported. Here, the importance of azepine analogs and azepine-related scaffolds in drug design and discovery for various diseases such as antimicrobial, anticonvulsive, analgesic, etc. has been described. Particularly, the most remarkable azepine therapeutic molecules are emphasized via structure–activity relationship. The review specially focused on disorders of central nervous system (convulsions, pain, anxiety, Alzheimer’s, and mood disorder). In this review, it is found that heterocycle-fused azepine derivatives bestowed the most promising activity. The review might be a real help to researchers in finding efficient azepine-based pharmacological agents in future.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.